T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$4.45B |
| 2 |
JPMorgan Chase
JPM
|
+$2.22B |
| 3 |
Atlassian
TEAM
|
+$2.08B |
| 4 |
NVIDIA
NVDA
|
+$1.81B |
| 5 |
Apple
AAPL
|
+$1.67B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$3.24B |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.08B |
| 3 |
Microsoft
MSFT
|
+$2.68B |
| 4 |
Wells Fargo
WFC
|
+$1.93B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.86B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.79% |
| 2 | Healthcare | 17.2% |
| 3 | Consumer Discretionary | 15.17% |
| 4 | Financials | 10.75% |
| 5 | Communication Services | 10.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CVAC
1376
DELISTED
CureVac
CVAC
| $8.84M | ﹤0.01% |
450,642
-53,506
| -11% | -$1.07M |
|
1377
Envista
NVST
$4.53B
| $8.84M | ﹤0.01% |
181,401
+10,873
| +6% | +$502K |
|
1378
Genius Sports
GENI
$2.31B
| $8.77M | ﹤0.01% |
1,906,493
+732,935
| +62% | +$4.22M |
|
1379
Arcutis Biotherapeutics
ARQT
$3.26B
| $8.64M | ﹤0.01% |
448,702
-374,466
| -45% | -$6.33M |
|
1380
Armstrong World Industries
AWI
$7.66B
| $8.62M | ﹤0.01% |
95,716
-3,970,477
| -98% | -$385M |
|
1381
Kyndryl
KD
$2.89B
| $8.6M | ﹤0.01% |
655,347
-273,528
| -29% | -$4.12M |
|
1382
PVH
PVH
$3.75B
| $8.53M | ﹤0.01% |
111,330
-8,892
| -7% | -$823K |
|
|
XM
1383
DELISTED
Qualtrics International Inc. Class A Common Stock
XM
| $8.51M | ﹤0.01% |
298,007
-2,600
| -0.9% | -$75.1K |
|
1384
Fidelity National Financial
FNF
$13.3B
| $8.3M | ﹤0.01% |
176,827
+12,828
| +8% | +$613K |
|
1385
Regenxbio
RGNX
$698M
| $8.3M | ﹤0.01% |
250,117
-63,139
| -20% | -$1.75M |
|
1386
Barings BDC
BBDC
$976M
| $8.2M | ﹤0.01% |
793,160
+82,308
| +12% | +$883K |
|
1387
ChargePoint
CHPT
$161M
| $8.14M | ﹤0.01% |
20,472
+602
| +3% | +$186K |
|
1388
VICI Properties
VICI
$29.1B
| $8.12M | ﹤0.01% |
285,291
+42,796
| +18% | +$1.2M |
|
|
LIAN
1389
DELISTED
LianBio American Depositary Shares
LIAN
| $8.09M | ﹤0.01% |
2,242,389
| – | – |
|
1390
WillScot Mobile Mini Holdings
WSC
$4.34B
| $8.08M | ﹤0.01% |
206,586
+8,964
| +5% | +$337K |
|
1391
Flywire
FLYW
$2.26B
| $8.04M | ﹤0.01% |
262,982
-2,640,628
| -91% | -$75.2M |
|
1392
Crown Holdings
CCK
$13B
| $8M | ﹤0.01% |
63,925
+3,808
| +6% | +$450K |
|
1393
Ally Financial
ALLY
$13.6B
| $7.95M | ﹤0.01% |
182,888
+11,364
| +7% | +$537K |
|
1394
Orchestra BioMed
OBIO
$260M
| $7.87M | ﹤0.01% |
794,078
-4,605
| -0.6% | -$45.5K |
|
1395
Ovintiv
OVV
$17.4B
| $7.86M | ﹤0.01% |
145,351
+30,555
| +27% | +$1.32M |
|
|
LBPH
1396
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| $7.85M | ﹤0.01% |
1,512,239
-512,377
| -25% | -$2.43M |
|
1397
ZTO Express
ZTO
$17.4B
| $7.71M | ﹤0.01% |
308,200
+35,487
| +13% | +$1M |
|
1398
Jones Lang LaSalle
JLL
$17B
| $7.7M | ﹤0.01% |
32,150
+1,337
| +4% | +$326K |
|
1399
OGE Energy
OGE
$9.81B
| $7.63M | ﹤0.01% |
187,040
+8,943
| +5% | +$339K |
|
1400
iShares Core US Aggregate Bond ETF
AGG
$138B
| $7.53M | ﹤0.01% |
70,254
+48,928
| +229% | +$5.38M |
|
Similar funds
T. Rowe Price Associates's Q1 2022 Portfolio in Review
As of Q1 2022, T. Rowe Price Associates held 3,085 positions worth $992B, down 11% from $1.11T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
T. Rowe Price Associates's Q1 2022 filing shows 108 new, 1,637 increased, 1,059 reduced and 107 closed positions. Its largest new stake was Nutrien: 6,143,560 shares worth $639M. The largest sale was Alphabet (Google) Class C, an estimated $3.24B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2022 buy was Nutrien: 6,143,560 shares worth $639M.
- T. Rowe Price Associates added most to Tesla in Q1 2022, an estimated $4.45B increase.
- T. Rowe Price Associates's biggest Q1 2022 reduction was Alphabet (Google) Class C, cutting an estimated $3.24B.
- T. Rowe Price Associates fully exited Xilinx Inc in Q1 2022, selling an estimated $481M.
- T. Rowe Price Associates's ten largest holdings make up 28% of its $992B portfolio in Q1 2022.
- T. Rowe Price Associates opened 108 new positions and closed 107 in Q1 2022.
- T. Rowe Price Associates's portfolio value fell 11% quarter-over-quarter to $992B.
Based on T. Rowe Price Associates's 13F filing for Q1 2022, filed 16 May 2022.